Technical Analysis for HARP - Harpoon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 11.35 -12.89% -1.68
HARP closed down 12.89 percent on Monday, April 22, 2019, on 22 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical HARP trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
180 Bullish Setup Bullish Swing Setup -12.89%
Wide Bands Range Expansion -12.89%
Overbought Stochastic Strength -12.89%
Stochastic Sell Signal Bearish -9.99%

Older signals for HARP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. It is involved in developing HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer; and HPN536 for the treatment of ovarian cancer and other mesothelin expressing tumors, as well as other products targeting tumor-associated antigens for the treatment of multiple myeloma and small-cell lung cancer. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Medicine Cancer Medical Specialties Diseases Immunotherapy Oncology Prostate Cancer Cancer Immunotherapy Ovarian Cancer Multiple Myeloma Tumors Proteins Treatment Of Ovarian Cancer Metastatic Castration Resistant Prostate Cancer Neuvenge
Is HARP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.85
52 Week Low 9.0651
Average Volume 89,214
200-Day Moving Average 0.0
50-Day Moving Average 12.8318
20-Day Moving Average 11.527
10-Day Moving Average 12.542
Average True Range 0.9349
ADX 18.56
+DI 21.6102
-DI 25.4273
Chandelier Exit (Long, 3 ATRs ) 10.4253
Chandelier Exit (Short, 3 ATRs ) 11.869799999999999
Upper Bollinger Band 13.8763
Lower Bollinger Band 9.1777
Percent B (%b) 0.46
BandWidth 40.76169
MACD Line -0.0132
MACD Signal Line -0.1932
MACD Histogram 0.18
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.17
Resistance 3 (R3) 14.40 13.69 13.70
Resistance 2 (R2) 13.69 12.97 13.58 13.54
Resistance 1 (R1) 12.52 12.53 12.17 12.29 13.39
Pivot Point 11.81 11.81 11.63 11.70 11.81
Support 1 (S1) 10.64 11.09 10.29 10.41 9.31
Support 2 (S2) 9.93 10.65 9.82 9.16
Support 3 (S3) 8.76 9.93 9.00
Support 4 (S4) 8.53